BBC journalist Graham Easton investigates the future of drug trials following the events of trial TGN1412.The BBC interviewer talks to Professor Gordon Duff (Commission on Human Medicines), Professor Andre Mclean (Imperial College London), Dr Jörg Täubel (Richmond Pharmacology), Professor Terry Hamblin (University of Southampton), Dr Ganesh Suntharalingam (Northwick Park Hospital), Professor Deborah Saltman (BioMedical Central), Dr Elaine Godfrey (MHRA), and Dr Mark Lewis (Strategic Health Authority), to get their opinion leading analysis of the event and the future of drug trials, covering:

  • What can be learnt and changed from the incident?
  • Should all first in man trials be conducted in a Hospital setting?
  • Regulatory issues

Click here to read the transcript

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event